There was no significant correlation (p > 0.05) between the percentage of Th17 cells in the PB and the plasma IL-17A level and between the percentage of Th17 cells and concentration of IL-17A in the PF of ovarian cancer patients. This evidence concerns the gene IL17A and ovarian cancer.